Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

Delayed Data
As of Aug 21
 -0.07 / -0.18%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 28 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 46.67, with a high estimate of 54.83 and a low estimate of 32.92. The median estimate represents a +20.65% increase from the last price of 38.68.

Analyst Recommendations

The current consensus among 32 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.85%
Growthannually 13.93%


Growthquarterly 8.66%
Growthannually 14.40%
Key to the earnings and sales forecast charts.